Financials data is unavailable for this security.
Cash flow in CADView more
In 2023, Satellos Bioscience Inc increased its cash reserves by 1,046.93%, or 20.14m. Cash Flow from Financing totalled 51.03m or -- of revenues. In addition the company used 14.50m for operations while cash used for investing totalled 17.54m.
Cash flow per share | -0.2527 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1816 |
---|---|
Tangible book value per share | 0.1816 |
More ▼
Balance sheet in CADView more
Current ratio | 6.68 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼